Page 12 - Serum Institute Of India

Stigmatised capital

Poonawalla's comments reveal the pitfalls of doing business in India

Serum Institute of India leads cross-sector Indian investments into UK

The Serum Institute of India will invest 240 million pounds in the UK to expand its vaccine business

Covid-19 2nd wave: Reports of no fresh vaccine order incorrect, says govt

Business Standard had reported in Monday's edition of the newspaper that the Centre had not yet placed fresh orders with the vaccine manufacturers. We stand corrected.

Have got full advance for 110 mn doses, says Serum CEO Poonawalla

Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine

UK-India summit: Serum Institute set to invest 240 million pound in Britain

The Serum Institute of India will invest 240 million pound in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs

File complaint about threats: Maharashtra govt to SII CEO Poonawalla

A Maharashtra minister on Monday said Serum Institute of India's CEO Adar Poonawalla should lodge a police complaint in connection with the alleged threats that he has received

Serum CEO Adar Poonawalla says will return to India in a few days

On his stay in the UK, the Serum Institute of India (SII) head said that he "had an excellent meeting" with all partners and stakeholders in that country

Getting aggressive calls from powerful Indians: SII CEO on vaccine pressure

Adar Poonawalla told UK's The Times in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield

Serum Institute plans to start vaccine production outside India: Report

Adar Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July

Serum cuts Covishield price by 25% for states, no change for pvt hospitals

Bharat Biotech is yet to announce any change in prices of Covaxin

Unanswered questions

Govt should remove uncertainty about next phase of vaccination

Covid: Covishield price for states reduced by 25% to Rs 300 per dose

SII's CEO Adar Poonawalla took to Twitter to announce the 'philanthropic' gesture

After states' objection, Centre asks vaccine manufacturers to lower prices

SII and Bharat Biotech had announced prices for state government procurement and for institutional sale to private hospitals

State govts begin vaccine price negotiations, eye Rs 150 per dose

States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely

The politics of vaccines

Direct criticism for scarce or expensive vaccines at the government, not the private sector

Andhra Pradesh places order for 40 mn doses each of Covaxin, Covishield

The Andhra Pradesh government on Saturday placed an order for purchase of 40 mn doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1

BJP MLA from Gorakhpur calls Poonawalla a dacoit, asks govt to acquire SII

Radha Mohan Das Agarwal compared Serum Institute of India (SII), CEO, Adar Poonawalla with a 'dacoit' and also asked the government to 'acquire' the company under the Epidemic Diseases Act

'Have to see Americans vaccinated': US on India's call for easing exports

State Department spokesperson says US is the most affected country in the pandemic, has 'special responsibility' to its citizens.

Centre clears the air on procurement of Covishield vaccine for states

Vaccination for those aged above 18 years could see a slow start in May

Karnataka to purchase 10 mn doses of Covishield vaccine at Rs 400 crore

The Karnataka government on Thursday decided to purchase 1 crore doses of Covishield vaccine at a cost of Rs 400 crore.